Greater Houston Area Pediatric Bipolar Registry
GHAPBR
1 other identifier
observational
1,000
1 country
1
Brief Summary
The purpose of this study is to perform a comprehensive research assessment of children and adolescents who meet The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for Bipolar Disorder (BD) , offspring of a parent with BD, and healthy controls (HC), to obtain blood samples and saliva samples from each subject to allow the evaluation for BD biomarkers and genetic information, to notify participants about future research studies they may qualify for , to recommend follow-up with an outpatient provider if needed and to use magnetic resonance imaging (MRI) (structural MRI and diffusion tensor imaging) to investigate brain structures and relevant pathways associated with mood and behavioral regulation, conversion from softer forms of the BD spectrum (BD-NOS) to harder forms (BD-I and BD-II) and possible early identification.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 6, 2022
CompletedFirst Submitted
Initial submission to the registry
August 4, 2023
CompletedFirst Posted
Study publicly available on registry
October 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 6, 2046
February 18, 2026
February 1, 2026
5 years
August 4, 2023
February 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Positive Identification of Bipolar Disorder as Assessed by Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid 7.2) (child)
baseline, annually until participant turns 25 years of age
Study Arms (3)
Bipolar Patients
Offspring of Bipolar Parents
Healthy Control Subjects
Eligibility Criteria
Subjects will be recruited from the Harris County Psychiatric Center, Harris Center for Mental Health, Texana Behavioral Healthcare Clinic, and UT Child and Adolescent Outpatient Psychiatry Clinic at Behavioral Science Campus, community referrals, referrals from other health providers, as well as self-referrals.
You may qualify if:
- Any current mood state (in the case of bipolar subjects)
- For bipolar patients: DSM-V criteria for BD type I, BD type II, or BD NOS, as per the administration of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
- For the offspring of bipolar parents: at least one parent meeting DSM-V criteria for BD type I or BD type II, or BD NOS as per the administration of the MINI Adult
You may not qualify if:
- Autism Spectrum Disorder (ASD)
- Developmental Intellectual Disorder
- Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis)
- Schizophrenia
- Uncontrolled or severe medical problem per investigator judgment
- For the offspring: parents with a history of any brain diseases, including seizures, stroke, meningitis, encephalitis, dementia, and other degenerative brain diseases; parents with a history of intellectual disability
- Any Psychiatric Diagnosis
- Any family history of Bipolar Disorder, Psychotic Disorder, Schizophrenia, or Schizoaffective disorder in a first-degree relative
- Any family history of a neurological condition in a first-degree relative.
- Mental Retardation/Intellectual Disability
- Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis)
- Schizophrenia
- Uncontrolled or severe medical problem per investigator judgement
- Autism Spectrum Disorders (ASD)
- Intellectual Developmental Disorder
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77479, United States
Biospecimen
Approximately 2ml of Saliva will be collected and processed for DNA. Blood will be collected and plasma and peripheral blood mononuclear cells (PBMCs) will be isolated
Study Officials
- PRINCIPAL INVESTIGATOR
Jair C Soares, M.D. PhD
The University of Texas Health Science Center, Houston
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 19 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 4, 2023
First Posted
October 30, 2024
Study Start
December 6, 2022
Primary Completion (Estimated)
December 6, 2027
Study Completion (Estimated)
December 6, 2046
Last Updated
February 18, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share